Tag: Myron Cohen

Dr. Myron Cohen, who has been an infectious disease researcher and administrator at UNC Chapel Hill for more than four decades, was lauded worldwide in 2011 for leading a seminal study showing a stunning result:  Treating people with HIV with antiretroviral drugs could keep them from passing along human immunodeficiency...

In a commentary published by Nature Medicine, Dr. Myron Cohen and Dr. Joe Eron, leaders of the UNC Institute for Global Health and Infectious Diseases, identify numerous medical advances originating from U.S. federally funded HIV research. They say the future of HIV research and the U.S.’s scientific leadership depends on...

The National Institutes of Health held a congressional briefing July 9 at the Dirksen Senate Office Building in Washington, DC. Dr. Myron Cohen, director of the Institute for Global Health and Infectious Diseases, and Dr. Joe Eron, chief of infectious diseases, kicked off the briefing session with an overview of HIV...

Despite remarkable advances in HIV prevention strategies over the last 2 decades, 1.3 million people were diagnosed with new infections in 2022. Diversifying HIV prevention options is imperative because different populations may have different priorities that influence the acceptability, uptake, and durable use of prevention modalities. Realizing the potential of...

To reduce atherosclerotic cardiovascular disease (ASCVD) among people living in the US with human immunodeficiency virus (HIV, PLWH), it is critical to asess shortfalls in statin initiation. Stephen R. Cole, PhD, Myron S. Cohen, MD, Joseph J. Eron, MD, and Michelle Floris-Moore, MD, MS., aimed to describe patterns in clinically indicated...

The ID Fellowship Program led by Christopher Sellers, MD, MPH, held a reception for six graduating fellows at the Siena Hotel in Chapel Hill, on the evening of June 18. Joined by Joe Eron, MD, chief of the division of infectious diseases, Myron Cohen, MD, director of the Institute for...

Dr. Adaora Adimora was a distinguished physician-scientist who made exceptional contributions to the fields of HIV epidemiology and clinical care. To continue her legacy of work, ViiV Healthcare will fund two yearly fellowships, co-directed by Myron Cohen, MD, professor of medicine and director of the UNC Institute for Global Health and...

Michelle Floris-Moore, MD, MPH, professor of medicine and a member of the Institute for Global Health and Infectious Diseases, delivered the 2024 Norma Berryhill Distinguished Lecture on June 20. Her presentation honored the trailblazing work of her mentor, the late Adaora Adimora, who was selected as the 2023 distinguished lecturer...

The 2nd Annual Global Health Scholars Symposium took place Friday, Feb. 16, showcasing the impactful work of 43 trainees in the U.S. and around the world. Near and far, approximately 250+ participants came together to share and learn about global health research. Opening Remarks Suzanne Maman, PhD, the associate dean...

The 2nd Annual Global Health Scholars Symposium is scheduled for Friday, Feb. 16 from 9:15am-12pm! Presented by the UNC Institute for Global Health and Infectious Diseases (IGHID) and the UNC Gillings School of Global Public Health (GSGPH), the symposium will feature global health research from MD/PhD students, doctoral candidates, postdoctoral fellows and...

Hard-won gains in the long-running global HIV epidemic are in danger of being lost, argues Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP at Columbia University, in a new commentary published today in Science. Co-authored with Myron S. Cohen, MD, director of the Institute for Global Health and Infectious...

A generous gift from Hyman and Marietta Bielsky will fund a new clinic in Malawi for reproductive health and sexually transmitted infections. The new clinic will replace a 50-year-old infrastructure for sexually transmitted disease research and care, the place where UNC’s global health work began.   Long-lived friendships are special connections with those who knew...

HIV virus eradication is a complex health challenge due to its long-lived persistence and how it hides in latently infected cells that escape the body’s immune system. Effective HIV treatments have decreased the likelihood of someone developing AIDS, while helping individuals live long and healthy lives without transmission to sexual...

Almost 40 years after the discovery of HIV, a new NOVA program “Ending HIV in America” reflects on the history of one of the most elusive and deadly viruses to ever infect humans. Dr. Myron “Mike” Cohen, director of the UNC Institute for Global Health & Infectious Diseases is the...

The First Annual Global Health Scholars Symposium took place November 11, sponsored by the Institute of Global Health & Infectious Diseases (IGHID) and the Gillings School of Global Public Health (GSGPH). The symposium showcased over 30 investigators from UNC and global sites around the world, featuring MD/PhD students, doctoral candidates, postdoctoral...

This study led by the UNC Institute for Global Health & Infectious Diseases, will enroll 7,500 COVID-positive individuals to answer some of the biggest questions about COVID-19. Investigators explain the study in this video. Over two years into the COVID-19 pandemic and researchers still are looking to answer some of...

A big thanks to everyone who contributed to the success of IGHIDFest! during UNC Research Week. This was the first year that the Institute for Global Health & Infectious Diseases (IGHID) participated in the week long celebration of Carolina’s research and education enterprise. Our follow-up survey confirms what a recent study...

(Note: This post has been updated to reflect a schedule change.) Almost 40 years after the discovery of HIV, a new NOVA program “Ending HIV in America” reflects on the history of one of the most elusive and deadly viruses to ever infect humans. Myron “Mike” Cohen, MD, director of...

Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through...

The 2022 HPTN Annual Meeting took place June 5-8 in Washington, D.C., bringing hundreds of worldwide researchers, collaborators, community representatives, and government health officials together to share updates and accomplishments and re-engage with each other as a community. HPTN Principal Investigators Myron Cohen, MD, director of the UNC Institute for...